Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein"

Mol Genet Genomics. 2017 Jun;292(3):535-536. doi: 10.1007/s00438-017-1300-x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • CRISPR-Associated Protein 9 / genetics
  • CRISPR-Cas Systems / genetics*
  • Favism / genetics
  • Favism / prevention & control
  • Gene Editing / ethics*
  • Gene Editing / methods*
  • Genetic Therapy / ethics*
  • Genetic Therapy / methods*
  • Glucosephosphate Dehydrogenase / genetics
  • Humans
  • beta-Globins / genetics
  • beta-Thalassemia / genetics
  • beta-Thalassemia / prevention & control

Substances

  • beta-Globins
  • Glucosephosphate Dehydrogenase
  • CRISPR-Associated Protein 9